The current valuation score of Emergent BioSolutions Inc is 9.26, ranking 34 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -58.91, which is -119.16% below the recent high of 11.29 and -18.75% above the recent low of -69.96.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.